Figure 7.
Transverse sections of CBCNM preparations exposed to (a) vehicle (BSA); (b) A. rugosus venom (30 μg ml−1); (c) acanmyotoxin-1 (0.1 μM); (d) acanmyotoxin-1 (1 μM); (e) acanmyotoxin-1 (1 μM) in the presence of antivenom (5 units ml−1). Scale bars, 100 μm in all micrographs. Arrowheads indicate prominent vacuoles.